[vc_section][vc_row][vc_column][vc_single_image image=”77519″ img_size=”full”][vc_column_text]

Atlantis Bioscience is honored to be the gold sponsor of the Translational Medicine Research Symposium hosted by National University of Singapore (NUS) happening on the 3rd June 2022 at 9am. Professor Harvey F. Lodish, a molecular and cell biologist and a Professor of Biological engineering at the Massachusetts Institute of Technology (MIT) is invited as a keynote speaker at the symposium.

[/vc_column_text][vc_column_text]

During the translational medicine symposium, current research in the field of clinical and medical studies is presented. The research interests that will be explored include cancer biology, immunology, digital medicine, precision medicine, nanomedicine, aging, cardiovascular diseases, neuroscience, infectious diseases, developmental biology, synthetic biology, human potential, eye and other diseases.

[/vc_column_text][vc_column_text]

At this symposium, medical researchers will present their abstracts to an audience. They will discuss bench-to-bedside application of their research interests in order to find novel methods for diagnosing, treating, and preventing diseases.

[/vc_column_text][vc_column_text]

We will be participating in this event as an exhibitor and as a guest speaker where we will be showcasing our solutions and services that can assist medical researchers in their translational research.

[/vc_column_text][/vc_column][/vc_row][/vc_section]